U.S. Markets close in 38 mins
  • S&P 500

    3,843.03
    +13.69 (+0.36%)
     
  • Dow 30

    31,178.08
    -223.93 (-0.71%)
     
  • Nasdaq

    13,297.78
    +178.35 (+1.36%)
     
  • Russell 2000

    2,216.97
    +16.79 (+0.76%)
     
  • Crude Oil

    61.59
    -1.94 (-3.05%)
     
  • Gold

    1,726.80
    -48.60 (-2.74%)
     
  • Silver

    26.46
    -1.23 (-4.42%)
     
  • EUR/USD

    1.2080
    -0.0106 (-0.8698%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • Vix

    26.43
    -2.46 (-8.52%)
     
  • GBP/USD

    1.3942
    -0.0071 (-0.5089%)
     
  • USD/JPY

    106.5700
    +0.3400 (+0.3201%)
     
  • BTC-USD

    46,750.54
    -2,725.61 (-5.51%)
     
  • CMC Crypto 200

    934.65
    +1.51 (+0.16%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

Arena Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference on April 14

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, April 10, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, at 10:40 AM ET (7:40 AM PT).

A live webcast of the presentation will be posted under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event.

About Arena Pharmaceuticals
Arena Pharmaceuticals is uniquely positioned to develop best-in-disease medicines with optimized efficacy and safety for patients globally. Our drive to deliver a robust pipeline of novel, transformational medicines is grounded in two decades of world class G-protein-coupled receptor (GPCR) discovery research.

It is the breadth and depth of our portfolio, prioritization of drug development to meet unmet patient needs, strong financial health and growing, bold-thinking world-class team that gives Arena the ingredients and passion to build a sustainable, vibrant next-generation pharmaceutical company.

Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's participation in and webcast of the virtual fireside chat and Arena's position, drive, portfolio, prioritization, financial position, team, and building of the company. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Corporate Contact:
Megan E. Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations
mknight@arenapharm.com
858.210.3635

Arena Media Contact:
IR@arenapharm.com
858.453.7200

Arena Pharmaceuticals Logo
Arena Pharmaceuticals Logo
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-at-the-19th-annual-needham-virtual-healthcare-conference-on-april-14-301038849.html

SOURCE Arena Pharmaceuticals, Inc.